biogen

Page 4 of 4

Incoming Biogen CEO Michel Vounatsos
Health

Here’s Why Biogen Is Forking Over $1.25 Billion to a Small Danish Biotech

By
January 17, 2017
Novo Nordisk Chief Executive Officer Lars Soerensen Interview
Leadership

This Big Pharma Chief Was Just Named the World’s ‘Best-Performing’ CEO—Again

By
October 12, 2016
Biogen Drug Shows Early Promise against Alzheimer’s Disease
Tech

Biogen Drug Shows Early Promise against Alzheimer’s Disease

By
September 3, 2016
George Scangos, CEO of Biogen Inc. speaks during Reuters Health Summit in New York
Health

Biogen Shares Are Spiking On Rumors of a Mega-Deal With Its Rivals

By
August 2, 2016
Whistleblower Claims Celgene Colluded With Charities to Drive Profits
Health

Whistleblower Claims Celgene Colluded With Charities to Drive Profits

By
August 1, 2016
483106863
Health

Drug Companies Really Don’t Care About the Price Hike Backlash

By
July 14, 2016
Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?

Could a Molecular ‘On-Off Switch for Agony’ Lead to a Safer Painkiller?

By Damian Garde and STAT News
July 7, 2016
How Medical Researchers Are Breaking the Blood-Brain Barrier
Health

How Medical Researchers Are Breaking the Blood-Brain Barrier

By
June 28, 2016
Samsung Holds Shareholders Meeting
Tech

Samsung Has a Best-Selling American Drug in Its Crosshairs

By
May 24, 2016
Drugs From European Pharmaceuticals Companies As Stocks Outperformed The Stoxx 600 Index By 1.2 percentage Points
Finance

Biotech Stocks Are Down 25% So Far This Year

By
May 6, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance

These Biopharma Companies Are the World’s Top Shareholder Value Creators

By
May 3, 2016
Biogen to Fire Workers, Restructure R&D After Difficult Year
Health

Why Biogen Is Spinning Off its Hemophilia Drug Business

By
May 3, 2016
547016547
Health

Why Biogen Is Poaching This Pfizer Exec to Head Up Its R&D Shop

By
April 27, 2016
Trading On The Floor Of The NYSE As U.S. Stocks Rise With Oil After Best Weekly Gain Since November
Finance

Here’s Why Biogen’s Shares Are Climbing Today

By
April 21, 2016
The CEO of Valeant Pharmaceuticals has suggested that Allergan is fat, overstaffed and ripe for big
Health

Allergan Struck a $3.3 Billion Alzheimer’s Drug Deal Right After Its Pfizer Merger Collapsed

By
April 7, 2016

Most Popular